REFERENCES
- Ostrow S., Egorin M.J., Hahn D., Markus S., Aisner J., Chang P., LeRoy A., Bachur N.R., Wiernik O.H. High-Dose Cisplatin therapy Using Mannitol Versus Furosemide Diuresis: Comparative Pharmacokinetics and Toxicity. Cancer Treat. Rep. 1981; 65: 73–78
- Hayes D.M., Cvitkovic E., Golbey R.B., Scheiner E., Helson L., Krakof I.H. High Dose Cisplatin Diamine Dichloride: Amelioration of Renal Toxicity by Mannitol Diuresis. Cancer 1977; 39: 1372–1381
- Salahudeen A., Poovala V., Parry W., Pande R., Kanji V., Ansari N., Morrow J., Roberts J. Cisplatin Induces N-Acetyl Cysteine Suppressible F2-Isoprostane Production and Injury in Renal Tubular Epithelial Cells. J. Am. Soc. Nephrol. 1998; 9(8)1448–1455
- Sheikh-Hamad D., Timmins K., Jalali Z. Cisplatin-Induced Renal Toxicity: Possible Reversal by N-Acetylcysteine Treatment. J. Am. Soc. Nephrol. 1997; 8: 1640–1645
- Borch R.F. The Nephrotoxicity of Antineoplastic Drugs. Toxicology of the Kidney; 2nd Ed. 1993; pp 283–301
- Safirstein R., Miller P., Dikman S., Lyman N., Shapiro C. Cisplatin Nephrotoxicity in Rats: Defect in Papillary Hypertonicity. Am. J. Physiol. 1982; 241: F175–F185
- Feinfeld D.A., Fuh V.L., Safirstein R. Urinary Glutathione-S-Transferase in Cisplatin Nephrotoxicity in the Rat. J. Clin. Chem. Clin. Biochem. 1986; 24: 529–532
- Courjault F., Leroy D., Coquery I., Toutain H. Platinum Complex-Induced Dysfunction of Cultured Renal Proximal Tubule Cells. Arch. Toxicol. 1993; 67: 338–346
- Gordon J.A., Gattone V.H. Mitochondrial Alterations in Cisplatin Induced Renal Failure. Am. J. Physiol. 1986; 264: F991–F998
- Brady H.R., Zeidel M.I., Kone B.C. Differential Actions of Cisplatin on Renal Proximal Tubule and Inner Medullary Collecting Duct Cells. J. Pharmacol. Exp. Ther. 1993; 219: 1421–1428
- Zhang R.K. Organic Anion Transport and Action of Glutamyl-Transpeptidase in Kidney Linked Mechanistically to Renal Tubule Uptake of Inorganic Mercury. Toxicol. Appl. Pharmacol. 1995; 132: 289–289
- Kronig R., Lichtenstein A.K., Nagami G.T. Sulphur-containing Amino Acids Decrease Cisplatin Cytotoxicity and Uptake in Renal Tubule Epithelial Cell Lines. Can. Chemo. and Pharmacol. 2000; 45(1)43–49
- Flanagan R.J., Meredith T.J. Use of N-Acetylcysteine in Clinical Toxicology. Am. J. Med. 1991; 91: 131s–139s
- Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The Antioxidant Action of N-Acetylcysteine: Its Reaction with Hydrogen Peroxide, Hydroxyl Radical, Superoxide, and Hypochlorous Acid. Free Radic. Biol. Med. 1989; 6: 593–597
- Appenroth D., Winnefeld K., Schroter H., Rost M. Beneficial Effect of Acetylcysteine on Cisplatin Nephrotoxicity in Rats. J. Appl. Toxicol. 1993; 13: 189–192
- Nanji A.A., Stewary D.J., Mikhael N.Z. Hyperuricemia and Hypoalbuminemia Predispose to Cisplatin-induced Nephrotoxicity, Cancer Chemother. Pharmacol. 1986; 17: 274–276
- Sugihara K., Nakano S., Gemba M. Stimulatory Effect of Cisplatin on Production of Lipid Peroxidation in Renal Tissues. Jpn. J. Pharmacol. 1987; 43: 247–252
- Hanneman J., Baumann K. Cisplatin Induced Lipid Peroxidation and Decrease of Gluconeogenesis in Rat Kidney Cortex: Different Effects of Antioxidants and Radical Scavengers. Toxicology 1988; 51: 119–132
- DiMari J., Megyesi J., Udvarhelyi N., Price P., Davis R., Safirstein R. N-Acetyl Cystine Ameliorates Ischemic Renal Failure. Am. J. Physiol. 1997; 272: F292–F298